Composition

Inventors

Jezek, Jan • GERRING, David • Howell, Sarah

Assignees

Arecor Ltd

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12239685-B2

Patent

Publication Date

2025-03-04

Expiration Date


Abstract

The invention provides inter alia an aqueous solution composition of pH in the range 6.0 to 8.0 comprising: —daptomycin or an analogue thereof, or a salt thereof; —a divalent metal cation; and —one or more salts which are not divalent metal cation salts or amino acid salts or buffer salts at a total concentration of 300 mM or more.

Core Innovation

The disclosed invention relates to an aqueous solution composition of pH in the range 6.0 to 8.0 comprising daptomycin, an analogue thereof, or a salt thereof at a total concentration of 30 mg/ml up to 100 mg/ml. The composition further comprises a divalent metal cation and a Group 1 metal halide at a total concentration of 300 mM to 2500 mM.

The invention emphasizes improved chemical and physical stability of the high-salt liquid formulation for daptomycin. The disclosed compositions are described as reducing impurities and providing a clear solution after storage compared with formulations with less salt and/or without divalent cations.

The formulation is described as substantially buffer-free, with buffer salts preferably minimized or avoided, including examples where phosphate, ADA, and particularly histidine at elevated levels have deleterious effects. The document also describes constraints for optional additives such that they do not increase the total buffer concentration.

Claims Coverage

The partial content includes one independent claim. The claim defines the core aqueous pH range and the combination of daptomycin, an analogue thereof, or a salt thereof with a divalent metal cation and a Group 1 metal halide across specified concentration ranges. Dependent claims refine quantitative ranges, specify particular divalent cations and halide selections, and impose buffer constraints.

Aqueous daptomycin solution with divalent cation and Group 1 metal halide at high concentration

An aqueous solution composition of pH 6.0 to 8.0 comprising daptomycin, an analogue thereof, or a salt thereof at a total concentration of 30 mg/ml up to 100 mg/ml; a divalent metal cation; and a Group 1 metal halide at a total concentration of 300 mM to 2500 mM.

Specified daptomycin concentration range

The aqueous solution composition comprises daptomycin, an analogue thereof, or a salt thereof at a total concentration of 40 mg/ml up to 60 mg/ml.

Specified divalent metal cation concentration range

The aqueous solution composition has the divalent metal cation at a total concentration of 10 mM to 150 mM.

Specified Group 1 metal halide concentration range

The aqueous solution composition includes the Group 1 metal halide at a total concentration of 400 mM to 2000 mM.

Selected divalent metal cations

The divalent metal cation is selected from calcium, magnesium, manganese, and zinc.

Substantially buffer-free aqueous solution composition

The aqueous solution composition is substantially free of buffers.

Taken together, the independent claim and its dependents define an aqueous pH 6.0 to 8.0 formulation containing daptomycin, an analogue thereof, or a salt thereof at 30 to 100 mg/ml, combined with a divalent metal cation and a Group 1 metal halide at 300 to 2500 mM. Dependent claims further narrow key concentration ranges, specify the divalent cations calcium, magnesium, manganese, and zinc, and impose a substantially buffer-free constraint.

Stated Advantages

Improved chemical and physical stability of the daptomycin high-salt liquid formulation.

Reduced impurities.

Provides a clear solution after storage.

Documented Applications

Treating bacterial infections.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.